Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers

NCT01684605 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: NESP 60μg
DRUG: CKD-11101 60μg

Sponsor

Chong Kun Dang Pharmaceutical

Collaborators

[object Object]